WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2012051614) DELIVERY OF HYDROPHOBIC BIOACTIVE AGENTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2012/051614    International Application No.:    PCT/US2011/056558
Publication Date: 19.04.2012 International Filing Date: 17.10.2011
IPC:
A61K 47/30 (2006.01), A61K 47/48 (2006.01), A61K 31/07 (2006.01), A61K 31/573 (2006.01), A61K 8/67 (2006.01), A61P 17/00 (2006.01), A61Q 19/00 (2006.01)
Applicants: KULESZA, John, E. [US/US]; (US)
Inventors: KULESZA, John, E.; (US)
Agent: GOULD, Weston, R.; Gifford, Krass, Sprinkle, Anderson & Citkowski, P.C 2701 Troy Center Drive, Suite 330 Post Office Box 7021 Troy, MI 48007-7021 (US)
Priority Data:
61/393,615 15.10.2010 US
Title (EN) DELIVERY OF HYDROPHOBIC BIOACTIVE AGENTS
(FR) ADMINISTRATION D'AGENTS BIOACTIFS HYDROPHOBES
Abstract: front page image
(EN)A composition for delivery of a hydrophobic bioactive agent is provided that provides for a partially solubilized storage solution that upon exposure to the air results in a fully solubilized bioactive agent in a molecular form for optimal delivery to the skin of a subject. The composition is used for the therapeutic treatment or diagnosis of numerous skin conditions such as acne, wrinkles, inflammation, and epidermal or musculoskeletal pain.
(FR)La présente invention concerne une composition pour administration d'un agent bioactif hydrophobe qui constitue une solution de stockage partiellement solubilisé qui, après exposition à l'air, conduit à un agent bioactif totalement solubilisé sous une forme moléculaire pour administration optimale à la peau d'un sujet. La composition est utilisée pour le traitement thérapeutique ou le diagnostic de nombreuses affections cutanées telles que l'acné, les rides, l'inflammation, et la douleur épidermique ou musculosquelettique.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)